![](https://cdn.sanity.io/images/0vv8moc6/curetoday/d715a2f1dcf34acf6d96213cfcf3423c1f2f9e5a-5616x3744.jpg?fit=crop&auto=format)
Tagrisso Associated With Cardiac Side Effects in Non-Small Cell Lung Cancer
Among patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), Tagrisso (osimertinib) was associated with a higher incidence of cancer therapy-related cardiac side effects (CTRCEs) compared with other EGFR tyrosine …